Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 6, 2022; 10(31): 11617-11624
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11617
Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report
Shu-Ying Zeng, Jin Yuan, Min Lv
Shu-Ying Zeng, Jin Yuan, Min Lv, Department of Oncology, The First People's Hospital of Longquanyi District Chengdu, Chengdu 652532, Sichuan Province, China
Author contributions: Zeng SY contributed to protocol/project development, data collection or management, data analysis, and manuscript writing/editing; Yuan J contributed to data collection and manuscript editing; Lv M contributed to protocol/project development and manuscript editing.
Informed consent statement: Informed written consent was obtained from the patient for the publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shu-Ying Zeng, CCST, Doctor, MSc, PhD, Doctor, Department of Oncology, The First People's Hospital of Longquanyi District Chengdu, No. 39 Mudan Street, Jinjiang District, Chengdu 652532, Sichuan Province, China. 18982193611@163.com
Received: July 14, 2022
Peer-review started: July 14, 2022
First decision: August 1, 2022
Revised: August 19, 2022
Accepted: September 21, 2022
Article in press: September 21, 2022
Published online: November 6, 2022
Core Tip

Core Tip: Herein, we present the case of a lymphoepithelioma-like carcinoma (LELC) patient who was successfully treated with sintilimab combined with paclitaxel and carboplatin. Recent literature on LELC is also reviewed and discussed for future avenues for LELC research.